Calm + Clarity Blend
Calm + Clarity · Calm Clarity Stack
The Calm + Clarity Blend combines PE-22-28, Pinealon, and Selank in a single vial for neuroprotective cognitive support with anxiolytic calming. This blend stands out for having the broadest peptide compatibility of any commercial blend because none of its three components contain methionine, tryptophan, cysteine, or histidine residues. This means it is fully compatible with both GHK-Cu (no oxidation-sensitive residues) and LL-37 (no anionic charge issues), making it the most flexible blend for multi-peptide syringe plans.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
How it works
The Calm + Clarity Blend provides layered neuroprotection and anxiolysis through three distinct mechanisms:
PE-22-28 Component: Derived from Prohibitin, this peptide interacts with mitochondrial and nuclear signaling pathways to enhance cellular stress resistance. PHB family proteins regulate mitochondrial morphogenesis, cell cycle progression, and transcriptional control. PE-22-28 enhances neuronal resilience against oxidative stress and metabolic insults at the cellular level.
Pinealon Component (Glu-Asp-Arg): As a Khavinson bioregulator, Pinealon penetrates cells and interacts directly with DNA at the level of histone modification and transcription factor accessibility. It modulates expression of genes involved in melatonin synthesis (AANAT, ASMT), circadian clock regulation, and neuroprotective pathways. Effects persist beyond the dosing period because gene expression changes are sustained through epigenetic mechanisms. Works at very low concentrations through direct DNA interaction rather than classical receptor binding.
Selank Component: Modulates GABA-A receptor sensitivity to enhance inhibitory neurotransmission without benzodiazepine-site binding. Influences serotonin metabolism through tryptophan hydroxylase activity and serotonin transporter dynamics. The tuftsin core provides immunomodulatory activity including enhanced phagocytic function and natural killer cell activity.
Synergy: PE-22-28 provides baseline neuroprotection at the mitochondrial level, Pinealon supports long-term neuronal health through epigenetic gene regulation, and Selank provides real-time anxiolytic calming. Together they create a multi-layered neuroprotective environment that supports both acute cognitive performance and long-term brain health.
What to expect
Days 1-7: Selank anxiolytic calming typically felt within 1-2 doses. Reduced anxiety and improved emotional regulation without sedation. PE-22-28 neuroprotective effects begin at the cellular level but are not subjectively noticeable this early. Pinealon begins gene expression modulation in pineal tissue. Mild injection site effects possible.
Weeks 2-4: Selank effects are well-established with consistent calm focus. Pinealon melatonin support may improve sleep onset and circadian consistency. PE-22-28 cellular stress resistance building cumulatively. Users often report a sustained sense of mental equilibrium and resilience to stress.
Weeks 4-12: Full benefits of the neuroprotective trio realized. Pinealon epigenetic changes become self-sustaining (effects persist after discontinuation). PE-22-28 cellular protection at maximum. Selank GABA modulation stable. Note that Pinealon as a bioregulator may benefit from course-style dosing (10-20 days) with extended rest periods, as its gene expression effects persist for months.
Evidence
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Dose/route: 5-10 units SubQ daily. No checked PubMed abstract administered the exact PE-22-28 + Pinealon + Selank blend by this route or dose. “Units” also cannot be mapped to a molecular dose from the abstract literature.
Mechanism for the exact three-component blend. No exact-blend abstract was found. Component or class evidence cannot establish synergy, formulation behavior, or the combined mechanism.
Primary safety concern / long-term combination safety. No human or animal abstract evaluated safety of this exact fixed combination and SubQ formulation.
The honest take
Broadest peptide compatibility of any commercial blend
Unproven in humansSupported by chemistry. None of the three components contain methionine, tryptophan, cysteine, or histidine residues, eliminating oxidation concerns with GHK-Cu. No anionic charge issues means compatibility with LL-37. This is a verifiable chemical property, not a clinical claim.
Partially supported. In vitro data confirms Pinealon interacts with DNA and modifies gene expression. The persistence of epigenetic changes beyond dosing is consistent with bioregulator theory and some animal data, but human duration-of-effect studies with modern methodology are lacking.
Supported by preclinical data only. PE-22-28 is derived from Prohibitin, a well-characterized mitochondrial protein. Cellular and animal studies show neuroprotective effects. No human data exists to confirm these effects translate to clinical benefit.
Interactions & stacking
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Documented together
Keep separate
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Side effects & safety
Commonly reported
- Mild injection site redness or warmth
- Occasional brief drowsiness from Selank (paradoxical in some users)
- Subtle shifts in sleep timing as circadian rhythms adjust
Less common & notes
- Rarely reported: mild headache, transient nausea.
- PE-22-28 has limited human safety data as a newer research compound.
- Selank is an approved medication in Russia with established safety.
- Pinealon is a bioregulator with decades of Russian clinical use.
- Long-term safety data for this specific combination does not exist.
Pharmacokinetics
PE-22-28: ~2 hours; Pinealon: ~30 min; Selank: ~30 min
PE-22-28: ~30 min; Pinealon: ~3 min; Selank: ~45 min
PE-22-28: ~10 hours; Pinealon: ~2.5 hours; Selank: ~2.5 hours
All ~100% SubQ; Selank ~92% nasal
PE-22-28: 12-24 hours (cellular stress resistance signaling); Pinealon: weeks to months (epigenetic gene expression changes persist beyond dosing); Selank: 6-12 hours (GABA/serotonin modulation)
Enzymatic degradation by aminopeptidases. Pro-Gly-Pro extension on Selank slows degradation. Pinealon effects persist through epigenetic mechanisms beyond peptide clearance.
Storage. Reconstitute with bacteriostatic water. Store refrigerated at 2-8 degrees C. Shelf life approximately 28 days after reconstitution. This blend has good stability due to the absence of oxidation-sensitive residues (no Met, Trp, Cys, His). Do not freeze after reconstitution. Protect from light. Discard if cloudy or particulate matter visible.
Regulatory status
Not FDA-approved. Selank is an approved prescription medication in Russia. PE-22-28 and Pinealon are classified as research peptides. Pinealon has decades of use in Russian bioregulator medicine. Available through compounding pharmacies and research suppliers. All use of this blend is experimental and off-label outside Russia.
Put it to work
Calculate, log & track
Open Calm + Clarity Blend straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Calm + Clarity Blend in the app →Go deeper
The guide & community
The complete Calm + Clarity Blend walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗